Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Stock buyback for AspenBio Pharma

The directors of Colorado, US-based AspenBio Pharma have authorized a common stock repurchase plan worth a maximum of $5m. Purchases of the company's shares will be made in routine, open-market transactions at the discretion of company management. The directors believe AspenBio Pharma's shares are undervalued at the present price and market capitalization. The program will allow AspenBio Pharma to repurchase its shares in accordance with Securities and Exchange Commission requirements. It is to be funded by the company's working capital. AspenBio Pharma has around 31.3million outstanding common stock shares and approximately $25m in working capital. It will retire all purchased shares to the status of "authorized and unissued", increasing the percentage ownership of all current shareholders.




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts